Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapyHidemitsu Kitamura, Akinobu Taketomi, Yosuke Ohno et al.|Cancer Science|2017Cited by 295
IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cellsYosuke Ohno, Akinobu Taketomi, Hidemitsu Kitamura et al.|Cancer Immunology Immunotherapy|2016Cited by 116
IL6 Modulates the Immune Status of the Tumor Microenvironment to Facilitate Metastatic Colonization of Colorectal Cancer CellsYujiro Toyoshima, Akinobu Taketomi, Hidemitsu Kitamura et al.|Cancer Immunology Research|2019Cited by 96
Lack of interleukin‐6 in the tumor microenvironment augments type‐1 immunity and increases the efficacy of cancer immunotherapyYosuke Ohno, Hidemitsu Kitamura, Yujiro Toyoshima et al.|Cancer Science|2017Cited by 85
Anastomotic complications after laparoscopic total gastrectomy with esophagojejunostomy constructed by circular stapler (OrVil™) versus linear stapler (overlap method)Hideki Kawamura, Akinobu Taketomi, Yosuke Ohno et al.|Surgical Endoscopy|2017Cited by 79